SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001140361-23-032443
Filing Date
2023-06-30
Accepted
2023-06-30 16:06:11
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 ny20009510x1_f3.htm F-3 440730
2 EXHIBIT 4.2 ny20009510x1_ex4-2.htm EX-4.2 409072
3 EXHIBIT 4.3 ny20009510x1_ex4-3.htm EX-4.3 341329
4 EXHIBIT 5.1 ny20009510x1_ex5-1.htm EX-5.1 84557
5 EXHIBIT 5.2 ny20009510x1_ex5-2.htm EX-5.2 27662
6 EXHIBIT 23.1 ny20009510x1_ex23-1.htm EX-23.1 3432
7 FILING FEES TABLE ny20009510x1_ex107.htm EX-FILING FEES 91906
8 logo_inflarx.jpg GRAPHIC 27642
9 ny20009510x1_barchart01x1.jpg GRAPHIC 324631
10 ny20009510x1_ex5-1img01.jpg GRAPHIC 1816
11 ny20009510x1_ex5-2img01.jpg GRAPHIC 4861
12 ny20009510x1_ex5-2img02.jpg GRAPHIC 2376
  Complete submission text file 0001140361-23-032443.txt   1897424
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-273058 | Film No.: 231061724
SIC: 2834 Pharmaceutical Preparations